Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12331279
Systems for producing cellular immunotherapeutics and methods of use thereof
granted -
US 12329829
Kit for radiolabelling with 68GA comprising a metal inhibitor
granted -
US 12331130
DDR1 antibodies and uses thereof
granted -
US 12329744
Methods of preparing extrudates
granted -
US 12331132
Multispecific polypeptide constructs having constrained CD3 binding and related methods and uses
granted -
US 12329784
Gut microbiota and treatment of cancer
granted -
US 12329780
Acute and chronic mitochondrial electron transport chain dysfunction treatments and graphenic materials for use thereof
granted -
US 12329909
Airway management systems for pulmonary disorder treatment
granted -
US 12331328
CRISPR/Cas9-mediated exon-skipping approach for USH2A-associated usher syndrome
granted -
US 12331334
Modified urokinase-type plasminogen activator polypeptides and methods of use
granted -
US 12331105
Broadly neutralizing antibodies against HIV
granted -
US 12329751
Topical roflumilast formulation having antifungal properties
granted -
US 12329772
Methods and compositions for administration of iron
granted -
US 12329805
Dosage forms of tissue kallikrein 1
granted -
US 12331040
Substituted benzofuranyl and benzoxazolyl compounds and uses thereof
granted -
US 12329825
Muscle targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of use thereof to induce exon skipping of exon 44 of dystrophin in a subject
granted -
US 12329827
Devices, compositions and related methods for accelerating and enhancing bone repair
granted -
US 12331056
SHP2 phosphatase inhibitors and methods of use thereof
granted -
US 12329756
Regulation of eIF4E activity for migraine therapy
granted -
US 12329816
Immunotherapy with metabolic enzyme expression
granted -
US 12331058
SHP2 and CDK4/6 dual-target inhibitory compound and pharmaceutical composition containing the same
granted -
US 12331109
Antigen binding molecule formats
granted -
US 12329824
Muscle targeting complexes and uses thereof for treating dystrophinopathies
granted -
US 12331078
Stabilizing mutants of prefusion SARS-CoV-2 (COVID-19) spike protein and improved yeast surface display engineering platform for the same
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.